Vaylenx is a biotechnology company developing a larvicide to reduce vector born disease carried by mosquito.
Vaylenx is a company that specializes in developing biotechnology vector control methods and solutions. The company was founded in 2015, in Washington, District of Columbia, United States.
Their solutions have been designed to fight against and repel mosquitoes and other insect pests, as well as vector borne diseases. Fighting against mosquito-spread diseases and slowing the widespread effects of them through ecological chemical products is the strategy of Vaylenx.